Nanobodies restore stability to cancer-associated mutants of tumor suppressor protein p16INK4a
Burbidge, O., Pastok, M.W., Hodder, S.L., Zenkeviciute, G., Noble, M.E.M., Endicott, J.A., Itzhaki, L.To be published.
Experimental Data Snapshot
wwPDB Validation   3D Report Full Report
Entity ID: 1 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Camelid nanobody NB09 | A [auth AAA] | 132 | Lama glama | Mutation(s): 0  | |
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
Sequence AnnotationsExpand | |||||
|
Entity ID: 2 | |||||
---|---|---|---|---|---|
Molecule | Chains | Sequence Length | Organism | Details | Image |
Cyclin-dependent kinase inhibitor 2A | B [auth BBB] | 175 | Homo sapiens | Mutation(s): 0  Gene Names: CDKN2A, CDKN2, MTS1 | |
UniProt & NIH Common Fund Data Resources | |||||
Find proteins for P42771 (Homo sapiens) Explore P42771  Go to UniProtKB:  P42771 | |||||
PHAROS:  P42771 GTEx:  ENSG00000147889  | |||||
Entity Groups   | |||||
Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
UniProt Group | P42771 | ||||
Sequence AnnotationsExpand | |||||
|
Length ( Å ) | Angle ( ˚ ) |
---|---|
a = 42.119 | α = 90 |
b = 182.931 | β = 90 |
c = 65.225 | γ = 90 |
Software Name | Purpose |
---|---|
REFMAC | refinement |
DIALS | data reduction |
PHASER | phasing |
Coot | model building |
Funding Organization | Location | Grant Number |
---|---|---|
Medical Research Council (MRC, United Kingdom) | United Kingdom | MR/N009738/1 |